A telemedicine system in the assessment of risks for socially significant chronic non-communicable diseases

DOI: https://doi.org/10.29296/25877305-2020-10-13
Download full text PDF
Issue: 
10
Year: 
2020

P. Seliverstov(2), Candidate of Medical Sciences, S. Bakaeva(1); Professor V. Shapovalov(2), TD
(1)I.I. Mechnikov North-Western State Medical University, Ministry of Health of Russia, Saint Petersburg
(2)Saint Petersburg State Electrotechnical University (LETI), Ministry of Science and Higher Education of
Russia

One of the pressing problems of modern healthcare is a steady increase in the proportion of chronic non-communicable diseases (CNCDs) that are most commonly caused by an improper lifestyle. Timely identification of risk factors contributing to the development of CNCDs will be able to preserve and considerably augment the health of each person and the general population. For effective screening of risk factors for CNCDs, preventive medical examination programs have been introduced into practical health care. Screening programs make it possible to detect diseases at earlier stages and, accordingly, to use a wider range of therapy options, which eventually enhances treatment efficiency and reduces the risks of possible adverse consequences. One of the possible options for the widespread introduction of screening programs is telemedicine. The advantages of the latter include reducing the number of medical errors, saving the time of a physician and a patient, enhancing the effectiveness of medical and preventive establishments, high-quality diagnosis and prevention of diseases, regardless of the patient’s area of residence. The use of telemedicine technologies became especially relevant during the COVID-19 pandemic. The forced cancellation of full-time visits to the physician, the reprofiling of hospitals, and implemented lockdowns served as an impetus for the development of telemedicine in both Russia and foreign countries. Telemedicine under pandemic conditions makes it possible to closely monitor the patient without the need for movement around the city and for a direct physical contact, which ultimately assists in reducing the spread of infection.

Keywords: 
telemedicine
prevention
screening
risk calculations
chronic non-communicable diseases
COVID-19



It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Chronic non-communicable diseases. Fact sheet: World Health Organization, 2015. URL: http://www.who.int/mediacentre/factsheets/fs355/en/
  2. Profilaktika hronicheskih neinfektsionnyh zabolevanij: rekomendatsii. Pod red. S.A. Bojtsova, A.G. Chuchalina. M., 2013; 128 s. [Profilaktika khronicheskikh neinfektsionnykh zabolevanii: rekomendatsii. Pod red. S.A. Boitsova, A.G. Chuchalina. M., 2013; 128 s. (in Russ.)].
  3. Federal'nyj zakon ot 21.11.2011 №323-FZ (red. ot 29.12.2015) «Ob osnovah ohrany zdorov'ja grazhdan v Rossijskoj Federatsii» [Federal’nyi zakon ot 21.11.2011 №323-FZ (red. ot 29.12.2015) «Ob osnovakh okhrany zdorov’ya grazhdan v Rossiiskoi Federatsii» (in Russ.)]. URL: http://www.consultant.ru/document/cons_doc_LAW_121895/
  4. Prikaz Minzdrava Rossii ot 03.02.2015 №36an «Ob utverzhdenii porjadka provedenija dispanserizatsii opredelennyh grupp vzroslogo naselenija» [Prikaz Minzdrava Rossii ot 03.02.2015 №36an «Ob utverzhdenii poryadka provedeniya dispanserizatsii opredelennykh grupp vzroslogo naseleniya» (in Russ.)] URL: https://normativ.kontur.ru/document?moduleId=1&documen tId=297174/
  5. Regional Office for Europe. Cancer. Screening and early detection. Fact sheet: World Health Organization, 2016. URL: http://www.euro.who.int /en/health-topics/noncommunicable-diseases/cancer/policy/screening-and-earlydetection
  6. Population screening programmes – guidance. NHS population screening explained. Fact sheet: UK National Screening Committee (UK NSC), 2013. URL: https://www.gov.uk/guidance/nhs-population-screening-explained
  7. Vsemirnaja organizatsija zdravoohranenija. Doklad o rezul'tatah vtorogo global'nogo obsledovanija v oblasti elektronnogo zdravoohranenija. 2012 g. [Vsemirnaya organizatsiya zdravookhraneniya. Doklad o rezul’tatakh vtorogo global’nogo obsledovaniya v oblasti elektronnogo zdravookhraneniya. 2012 g. (in Russ.)].
  8. Kim J., Alanazi H., Daim T. Prospects for Telemedicine Adoption: Prognostic Modeling as Exemplified by Rural Areas of USA. Foresight and STI Governance. 2015; 9 (4): 32–41. DOI: 10.17323/1995-459x.2015.4.32.41
  9. Nelson R. Telemedicine and Telehealth. Am J Nurs. 2017; 117 (6): 17–8. DOI: 10.1097/01.NAJ.0000520244.60138.1c
  10. Vidal-Alaball J. et al. Telemedicine in the face of the COVID-19 pandemic. Aten Primaria. 2020; 52 (6): 418–22. https://doi.org/10.1016/j.aprim.2020.04.003
  11. Kiseleva A. Prosto sprosit': koronavirus podstegnul spros na onlajn-doktorov v Rossii. Rossija Segodnja. Vypusk ot 19 maja 2020 [Kiseleva A. Prosto sprosit’: koronavirus podstegnul spros na onlain-doktorov v Rossii. Rossiya Segodnya. Vypusk ot 19 maya 2020 (in Russ.)]. URL: https://1prime.ru/state_regulation/20200519/831468461.html
  12. Skobelev V. Pravitel'stvo poprosili razreshit' vracham stavit' diagnozy cherez internet. RBK. Vypusk ot 19 marta 2020 [Skobelev V. Pravitel’stvo poprosili razreshit’ vracham stavit’ diagnozy cherez internet. RBK. Vypusk ot 19 marta 2020 (in Russ.)]. URL: https://www.rbc.ru/technology_and_media/19/03/2020/5e72097e9a794721221e1a46?from=newsfeed
  13. Hong Z., Li N., Li D. et al. Telemedicine During the COVID-19 Pandemic: Experiences From Western China. J Med Internet Res. 2020; 22 (5): e19577. DOI: 10.2196/19577
  14. Liu X., Luo H., Zhang L. et al. Telephone-based re-education on the day before colonoscopy improves the quality of bowel preparation and the polyp detection rate: a prospective, colonoscopist-blinded, randomised, controlled study. Gut. 2014; 63: 125–30. DOI: 10.1136/gutjnl-2012-304292
  15. Cross R.K., Jambaulikar G., Langenberg P. et al. TELEmedicine for Patients with Inflammatory Bowel Disease (TELE-IBD): Design and implementation of randomized clinical trial. Contemp Clin Trials. 2015; 42: 132–44. DOI: 10.1016/j.cct.2015.03.006
  16. Elkjaer M., Shuhaibar M., Burisch J. et al. E-health empowers patients with ulcerative colitis: a randomised controlled trial of the web-guided ‘Constant-care’ approach. Gut. 2010; 59: 1652–61. DOI: 10.1136/gut.2010.220160
  17. Pedersen N., Elkjaer M., Duricova D. et al. eHealth: individualisation of infliximab treatment and disease course via a self-managed web-based solution in Crohn’s disease. Aliment Pharmacol Ther. 2012; 36: 840–9. DOI: 10.1111/apt.12043
  18. Xia W. et al. Transmission of coronavirus disease 2019 during the incubation period may lead to a quarantine loophole. medRxiv (preprint 2020). https://doi.org/10.1101/2020.03.06.20031955
  19. Hollander J.E., Carr B.G. Virtually Perfect? Telemedicine for Covid-19. N Engl J Med. 2020; 382 (18): 1679–81. DOI: 10.1056/NEJMp2003539
  20. Lurie N., Carr B.G. The Role of Telehealth in the Medical Response to Disasters. JAMA Internal Medicine. 2018; 178 (6): 745–6. DOI: 10.1001/jamainternmed.2018.1314
  21. Bojtsov S.A., Chuchalin A.G., Arutjunov G.P. i dr. Profilaktika hronicheskih neinfektsionnyh zabolevanij. Rekomendatsii. M., 2013; s. 5–6 [Boitsov S.A., Chuchalin A.G., Arutyunov G.P. et al. Profilaktika khronicheskikh neinfektsionnykh zabolevanii. Rekomendatsii. M., 2013; s. 5–6 (in Russ.)]. URL: http://webmed.irkutsk.ru/doc/pdf/prevent.pdf
  22. Siegel C.A. Transforming Gastroenterology Care With Telemedicine. Gastroenterology. 2017; 152 (5): 958–63. DOI: 10.1053/j.gastro.2017.01.048
  23. Dorsey E.R., Topol E.J. State of Telehealth. N Engl J Med. 2016; 375 (2): 154–61. DOI: 10.1056/NEJMra1601705